Immunology/Cell Biology Seminar

Description:

For More Information About This Series Contact:
Dr. Diana Linnekin
Phone: 301-846-5631
E-Mail: linnekin@ncifcrf.gov
Web:

Series Calendar:
12/8/2006	Yong-Jun Liu, MD, PhD	Dendritic Cells and Immunity
12/1/2006	Raymond P. Donnelly, PhD	Shared Use of the IL-10 Receptor-2 Chain by IL-22 and Interferon-Lambda
10/27/2006	Dr. B.J. Fowlkes	aB T Cell Development is Regulated by the TCR and Notch Signaling Pathways
10/20/2006	Dr. Zheng Cui	Innate Cancer Immunity in Mice and Humans
5/25/2006	Steven K. Libutti, MD	Endothelial Cell Monocyte Activating Polypeptide II (EMAP-II): Mechanism of Action and Implications for Cancer Therapy
5/19/2006	David Spencer, PhD	CANCELLED--Genetically Enhanced Dendritic Cells (eDCs): Novel 3rd Generation DC Vaccine Platform Technology for Cancer
5/5/2006	Stefanie Vogel, PhD	The Innate Immune Response to Francisella tularensis LVS: Role of TLR2
4/14/2006	Dr. Suzanne Ostrand-Rosenberg	Inflammation, Immune Suppression and Tumor Progression
4/7/2006	Dr. Graham P. Pawelec	Is It Still Worthwhile Seeking Individual Tumor Antigens for Use in Cancer Immunotherapy?
3/17/2006	Dr. William George Nelson, V	Inflammation, DNA Methylation, and the Epidemic of Prostate Cancer
2/24/2006	Russell D. Salter, PhD	Communication Between Immune Cells Mediated by Tunneling Nanotubules
2/10/2006	Dr. James W. Hodge	Vaccine Strategies and Combined Modalities for the Therapy of Cancer
1/27/2006	Dr. Michael Kron	Multifunctional Aminoacyl-tRNA Synthetases: The Way of the Parasite
1/13/2006	Dr. Charles T. Lutz	Dissecting the Onion - Multiple Layers of KIR Gene Expression Control
1/6/2006	Dr. Frank Cuttitta	Adrenomedullin - An Esoteric Growth Regulator of Human Cancers
11/4/2005	James A. Lederer, PhD	The Regulation of the Innate and Adaptive Immune Response to Injury
10/14/2005	Elizabeth Kovacs, PhD	Aging Impairs Macrophage Function After Injury
10/7/2005	Dr. Ronald Schwartz	T Cell Adaptive Tolerance
9/16/2005	Dr. Linda A. Sherman	Peripheral Tolerance of CD8 T Cells
9/9/2005	Sergio Lira, MD, PhD	Chemokines in Autoimmune Disease
8/18/2005	Cheryl Dixon, PhD	Alcohol's Effects on Hematopoiesis
7/29/2005	Dr. Jeffrey Dorfman	B Cell Memory to P. Falciparum Blood Stage Antigens in a Malaria Endemic Area
6/30/2005	Peter Blumberg, PhD	The Vanilloid Receptor as a Therapeutic Target for Pain and Inflammation
6/10/2005	Dr. David Kranz	Structure and Function Studies In Vitro Engineered, High-Affinity T Cell Receptors
6/3/2005	Dr. Albert Zlotnik	Gene Expression Analysis and the Role of Chemokines in Cancer
5/27/2005	Thomas Kupper, MD	Immunosurveillance and the Skin
5/13/2005	Andrew Weinberg, PhD	Molecular and Cellular Mechanisms that Drive Anti-OX-40-mediated Tumor Regression
1/28/2005	Dr. Silvia Vidal	Innate Resistance to Mouse Cytomegalovirus Infection is Associated With Epistatsis Between Activating Natural Killer Receptor and MHC Class I
12/17/2004	Giorgio Trinchieri, M.D.	Dendritic Cells And Their Cytokines At The Interface Of Innate Resistance and Adaptive Immunity
11/19/2004	Thomas Mitchell, PhD	Beyond Signal 2: How Do Adjuvants Boost T Cell Clonal Expansion?
10/1/2004	Dr. Nicholas P. Restifo	Translating Basic Immunology Into New Immunotherapies
4/9/2004	Dr. Elizabeth Repasky (Subjeck)	Identitication and Characterization of APO2L/TRAIL Sensitive and Resistant Patients' Tumors
4/2/2004	Eric O. Long, Ph.D.	Regulation of NK Cell Cytotoxicity by Positive and Negative Signals
4/1/2004	Dr. Graham Pawelec	Novel Immunotherapeutic Targets for Chronic Myelogenous Leukaemia
3/19/2004	Dr. Marius Sudol	The WW Domain: From the Proteomic Mapping to Signaling in Human Diseases
2/27/2004	Stefanie N. Vogel, Ph.D.	TLR4 Signaling: Turning It On and Turning It Off
2/13/2004	Dr. Kerry S. Campbell	The Inner Workings of KIR2DL4: A Potent NK Cell Activating Receptor That Works in Some of the People, Part of the Time
9/26/2003	Dr. Kenneth S. Tung, University of Virginia	Autoimmune Disease: The Interplay Between Antibody, T Cells and NK Cells
6/13/2003	William G. Kerr, University of South Florida, College of Medicine	LRBA and SHIP: Novel Targets in Cancer Therapy
5/2/2003	Jenny Gumperz, PhD	The Zen of NKT Cell Activation
3/28/2003	Dr. Joan Stein-Streilein, Schepens Eye Research Institute, Boston	"Mechanisms for the Generation of CD1d-Restricted NKT Cell Dependent CD8+ T Regulatory Cells"
3/14/2003	Dr. Peter Murray, St. Jude Children's Research Hospital	Regulation of Innate Immunity
3/7/2003	Michael S. Krangel, PhD, Duke University Medical Center	Chromatin Structure and the Developmental Regulation of V(D)J Recombination
2/28/2003	Stephen Katz, MD, NIAMSD	Mouse Models of Skin Autoimmunity and Peripheral Tolerance
2/21/2003	Richard M. Ransohoff, MD	Chemokines, Chemokine Receptors and the Nervous System: Clinical and Experimental Studies
2/14/2003	Dr. Jill Suttles	Lipid Binding Proteins as Novel Regulators of Macrophage Gene Expression and Pro-Inflammatory Function
2/7/2003	Fred Finkelman, MD, University of Cincinnati College of Medicine	What Stimulates the Th2 Response?
2/7/2003	Fred Finkelman, M.D.	What Stimulates the Th2 Response?
1/31/2003	Dr. Carole A. Parent, LCMB,NCI, NIH	"Chemotaxis: Leading From Behind"
1/24/2003	Thomas Rogers, Ph.D.	A Painful Experience: Cross-talk Between Opioid and Chemokine Receptors
1/24/2003	Thomas Rogers, PhD, Temple University School of Medicine	A Painful Experience: Cross-talk Between Opioid and Chemokine Receptors
1/17/2003	Dr. Mary Carrington, SAIC-Frederick	Genetic Effects of KIR Genes in Human Disease
1/17/2003	Dr. Mary Carrington	Genetic Effects of KIR Genes in Human Disease
1/3/2003	Dr. B.J. Fowlkes, NIAID	Lineage Commitment in Developing T Cells
12/13/2002	Dr. Thomas H. Bugge, NIDCR, NIH	"Tumor Treatment With Protease Activated Cytotoxins"
12/13/2002	Dr. Thomas H. Bugge, NIDCR, NIH	"Tumor Treatment With Protease Activated Cytotoxins"